-
Signature
-
/s/ Hing C. Wong, as Attorney-in-Fact for Peter Rhode
-
Stock symbol
-
HCWB
-
Transactions as of
-
Jul 19, 2021
-
Transactions value $
-
$0
-
Form type
-
3
-
Date filed
-
7/19/2021, 05:00 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
holding |
HCWB |
Common Stock |
|
|
|
|
|
34.3K |
Jul 19, 2021 |
Direct |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
holding |
HCWB |
Stock Option (Right to Buy) |
|
|
|
|
|
|
Jul 19, 2021 |
Common Stock |
51.4K |
$0.14 |
Direct |
F1 |
holding |
HCWB |
Stock Option (Right to Buy) |
|
|
|
|
|
|
Jul 19, 2021 |
Common Stock |
8.57K |
$0.21 |
Direct |
F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
Remarks:
Title of the Officer: Chief Scientific Officer and Vice President of Clinical Operations Exhibit 24.1: Power of Attorney